Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women

Abstract Objective To assess the effectiveness of metformin in the incidence of gestational diabetes mellitus (GDM) in obese pregnant women attending a public maternity hospital in Joinville, Santa Catarina, Brazil. Methods Randomized clinical trial including obese pregnant women with a body mas...

Full description

Bibliographic Details
Main Authors: Willian Barbosa Sales, Iramar Baptistella do Nascimento, Guilherme Dienstmann, Matheus Leite Ramos de Souza, Grazielle Dutra da Silva, Jean Carl Silva
Format: Article
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2018-04-01
Series:Revista Brasileira de Ginecologia e Obstetrícia
Subjects:
Online Access:http://www.scielo.br/pdf/rbgo/v40n4/0100-7203-rbgo-40-04-00180.pdf
_version_ 1819003470338850816
author Willian Barbosa Sales
Iramar Baptistella do Nascimento
Guilherme Dienstmann
Matheus Leite Ramos de Souza
Grazielle Dutra da Silva
Jean Carl Silva
author_facet Willian Barbosa Sales
Iramar Baptistella do Nascimento
Guilherme Dienstmann
Matheus Leite Ramos de Souza
Grazielle Dutra da Silva
Jean Carl Silva
author_sort Willian Barbosa Sales
collection DOAJ
description Abstract Objective To assess the effectiveness of metformin in the incidence of gestational diabetes mellitus (GDM) in obese pregnant women attending a public maternity hospital in Joinville, Santa Catarina, Brazil. Methods Randomized clinical trial including obese pregnant women with a body mass index (BMI) ≥ 30 kg/m2, divided into two groups (control and metformin). Both groups received guidance regarding diet and physical exercise. The participants were assessed at two moments, the first at enrollment (gestational age ≤ 20) and the second at gestational weeks 24-28. The outcomes assessed were BMI and gestational diabetes mellitus (GDM) diagnosis. The data distribution was assessed with the Friedman test. For all the analytical models, the p-values were considered significant when lower than 0.05. The absolute risk reduction was also estimated. Results Overall, 164 pregnant women were assessed and further divided into 82 participants per group. No significant difference was observed in BMI variation between the control and metformin groups (0.9 ± 1.2 versus 1.0 ± 0.9, respectively, p = 0.63). Gestational diabetes mellitus was diagnosed in 15.9% (n = 13) of the patients allocated to the metformin group and 19.5% (n = 16) of those in the control group (p = 0.683). The absolute risk reduction was 3.6 (95% confidence interval 8.0- 15.32) in the group treated with metformin, which was not significant. Conclusion Metformin was not effective in reducing BMI and preventing GDM in obese pregnant women.
first_indexed 2024-12-20T23:21:31Z
format Article
id doaj.art-f9cae49e0e84482fb3ae743d0f838432
institution Directory Open Access Journal
issn 0100-7203
language English
last_indexed 2024-12-20T23:21:31Z
publishDate 2018-04-01
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
record_format Article
series Revista Brasileira de Ginecologia e Obstetrícia
spelling doaj.art-f9cae49e0e84482fb3ae743d0f8384322022-12-21T19:23:31ZengFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia0100-72032018-04-0140418018710.1055/s-0038-1642632Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant WomenWillian Barbosa SalesIramar Baptistella do NascimentoGuilherme DienstmannMatheus Leite Ramos de SouzaGrazielle Dutra da SilvaJean Carl SilvaAbstract Objective To assess the effectiveness of metformin in the incidence of gestational diabetes mellitus (GDM) in obese pregnant women attending a public maternity hospital in Joinville, Santa Catarina, Brazil. Methods Randomized clinical trial including obese pregnant women with a body mass index (BMI) ≥ 30 kg/m2, divided into two groups (control and metformin). Both groups received guidance regarding diet and physical exercise. The participants were assessed at two moments, the first at enrollment (gestational age ≤ 20) and the second at gestational weeks 24-28. The outcomes assessed were BMI and gestational diabetes mellitus (GDM) diagnosis. The data distribution was assessed with the Friedman test. For all the analytical models, the p-values were considered significant when lower than 0.05. The absolute risk reduction was also estimated. Results Overall, 164 pregnant women were assessed and further divided into 82 participants per group. No significant difference was observed in BMI variation between the control and metformin groups (0.9 ± 1.2 versus 1.0 ± 0.9, respectively, p = 0.63). Gestational diabetes mellitus was diagnosed in 15.9% (n = 13) of the patients allocated to the metformin group and 19.5% (n = 16) of those in the control group (p = 0.683). The absolute risk reduction was 3.6 (95% confidence interval 8.0- 15.32) in the group treated with metformin, which was not significant. Conclusion Metformin was not effective in reducing BMI and preventing GDM in obese pregnant women.http://www.scielo.br/pdf/rbgo/v40n4/0100-7203-rbgo-40-04-00180.pdfobesitygestationgestational diabetes mellitusmetformin
spellingShingle Willian Barbosa Sales
Iramar Baptistella do Nascimento
Guilherme Dienstmann
Matheus Leite Ramos de Souza
Grazielle Dutra da Silva
Jean Carl Silva
Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
Revista Brasileira de Ginecologia e Obstetrícia
obesity
gestation
gestational diabetes mellitus
metformin
title Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
title_full Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
title_fullStr Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
title_full_unstemmed Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
title_short Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
title_sort effectiveness of metformin in the prevention of gestational diabetes mellitus in obese pregnant women
topic obesity
gestation
gestational diabetes mellitus
metformin
url http://www.scielo.br/pdf/rbgo/v40n4/0100-7203-rbgo-40-04-00180.pdf
work_keys_str_mv AT willianbarbosasales effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen
AT iramarbaptistelladonascimento effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen
AT guilhermedienstmann effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen
AT matheusleiteramosdesouza effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen
AT grazielledutradasilva effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen
AT jeancarlsilva effectivenessofmetformininthepreventionofgestationaldiabetesmellitusinobesepregnantwomen